Medigen Vaccines announced positive results of preclinical data for vaccine candidate against COVID-19
On Aug. 14, 2020, Medigen Vaccine Biologics (MBV) published preclinical results of their COVID-19 vaccine candidate in BioRxiv,…
Novavax and UK Government announced collaboration and purchase agreement for Novavax’ COVID-19 vaccine candidate
On Aug. 14, 2020, Novavax announced it had signed a Heads of Terms (Term Sheet) with the Government…
Novavax and SK bioscience announced collaboration for Novavax COVID-19 vaccine candidate
On Aug. 13, 2020, Novavax and SK bioscience announced a development and supply agreement for the antigen component…
Heat Biologics’ COVID-19 vaccine demonstrated robust T cell driven immune response to SARS-CoV-2 in preclinical studies
On Aug. 13, 2020, Heat Biologics reported preclinical data for Heat’s gp96-based COVID-19. The data, generated at the…
Pfizer and BioNTech announced publication of peer-reviewed data from phase 1/2 study of mRNA-based vaccine candidate
On Aug. 12, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their BNT162 mRNA-based vaccine development…
Biotechnology | Disease | HIV | Life Science News | Medicine | Therapeutics | Vaccine
China National Medical Products Administration approved Truvada for HIV pre-exposure prophylaxis
On Aug. 11, 2020, Gilead Sciences announced that the China National Medical Products Administration (NMPA) had approved a…
Moderna announced supply agreement with U.S. Government for initial 100 million doses of mRNA vaccine against COVID-19
On Aug. 11, 2020, Moderna announced that the U.S. government had secured 100 million doses of mRNA-1273. The…
IBIO-201 demonstrated ability to elicit anti-SARS-CoV-2 immune response in preclinical studies
On Aug. 10, 2020, iBio provided an update on one of its proprietary vaccine candidates being designed to…
Intravacc received US NIH/NIAID contract to develop Enterovirus D68 Vaccine
On Aug. 9, 2020, Intravacc announced that it had been awarded a contract with base and options that…
Scientists revealed structural details of spike protein used in leading COVID-19 vaccine
On Aug. 7, 2020, scientists at Scripps Research announced they had obtained high-resolution, atomic-scale details of the structure…
Altimmune Completed enrollment in phase 1b clinical trial of NasoShield, a single dose intranasal anthrax vaccine candidate
On Aug. 7, 2020, Altimmune announced that it had completed enrollment in its Phase 1b clinical trial of…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Nanotechnology | Pharmaceutical | Vaccine
Novavax and Takeda announced collaboration for Novavax COVID-19 vaccine candidate in Japan
On Aug. 7, 2020, Novavax and Takeda Pharmaceutical announced a partnership for the development, manufacturing and commercialization of…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Nanotechnology | Therapeutics | Vaccine
Novavax signed COVID-19 vaccine supply deal with India’s Serum Institute
On Aug. 6, 2020, Novavax announced it had entered a supply and license agreement with the Serum Institute…
NIH-Moderna investigational COVID-19 vaccine showed promise in mouse studies
On Aug. 5, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that the investigational vaccine…
BioNTech and Fosun Pharma announced start of clinical trial of mRNA-based COVID-19 vaccine candidate in China
On Aug. 5, 2020, BioNTech and Shanghai Fosun Pharmaceutical announced that the first 72 participants had been dosed…
Heat Biologics highlighted Importance of T cell immunity to prevent COVID-19
On Aug. 5, 2020, Heat Biologics highlighted the importance of T cell immunity in preventing COVID-19 in a…
Pfizer and BioNTech to supply Canada with their BNT162 mRNA- based vaccine candidate
On Aug. 5, 2020, Pfizer Canada and BioNTech announced an agreement with the Government of Canada to supply…
Novavax announced positive phase 1 data for its COVID-19 vaccine candidate
On Aug. 4, 2020, Novavax announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of…
ImmunityBio study showed positive T cell and antibody immune responses to its COVID-19 vaccine candidate
On Aug. 3, 2020, ImmunityBio announced positive preclinical results for its human Ad5 vaccine candidate that contains both…
Bio-Techne and Kantaro Biosciences to launch a quantitative research use only COVID-19 serology test
On Aug. 3, 2020, Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate…
Waisman Biomanufacturing partnered with Heat Biologics to manufacture COVID-19 vaccine
On Aug. 3, 2020, Waisman Biomanufacturing at the University of Wisconsinï¾–Madison announced it was partnering with Heat Biologics…
Serum Institute of India received approval to start human trials for Oxford vaccine
On Aug. 1, 2020, Novavax announced it had received approval to start human trials in India for the…
Pfizer and BioNTech announced an agreement with the MHLW in Japan to supply 120 million doses of BNT162 mRNA-based vaccine candidate
On Jul. 31, 2020, Pfizer and BioNTech announced an agreement with the Ministry of Health, Labour and Welfare…
Sanofi and GSK selected for Operation Warp Speed to supply US government with 100 million doses of COVID-19 vaccine
On Jul. 31, 2020, Sanofi and GSK announced a collaborative effort with the U.S. government to accelerate the…
Single dose of Johnson & Johnson COVID-19 vaccine candidate demonstrated robust protection in pre-clinical studies
On Jul. 30, 2020, Johnson & Johnson announced that its lead vaccine candidate protected against infection with SARS-CoV-2,…
Seqirus began shipping 2020/21 influenza vaccines to U.S. market
On Jul. 30, 2020, Seqirus announced it had begun shipping its portfolio of seasonal influenza vaccines to customers…
INOVIO’s COVID-19 DNA vaccine INO-4800 provided protection with memory immune responses In non-human primates challenged with SARS-CoV-2 virus
On Jul. 30, 2020, INOVIO announced that its COVID-19 DNA vaccine INO-4800 targeting SARS-CoV-2 was effective in protecting…
Intravacc and Celonic to develop and produce a novel COVID-19 vaccine
On Jul. 29, 2020, Intravacc and Celonic Group, a biopharmaceutical contract development and manufacturing organization (CDMO), announced that…
Heat Biologics COVID-19 vaccine demonstrated immunogenicity proof-of-concept in pre-clinical studies
On Jul. 29, 2020, Heat Biologics announced successful pre-clinical testing of the Company’s COVID-19 vaccine, which demonstrated in-vivo…
BARDA procured Regeneron’s REGN-EB3 investigational Ebola treatment for national preparedness
On Jul. 29, 2020, Regeneron announced that the Biomedical Advanced Research and Development Authority (BARDA) had entered into…